| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |